VBI Vaccines to Participate in the 2018 Oppenheimer Boston Oncology Insight Summit
July 09, 2018 08:00 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., July 09, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...